These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 17007555)

  • 1. CHK2-dependent phosphorylation of BRCA1 in hypoxia.
    Gibson SL; Bindra RS; Glazer PM
    Radiat Res; 2006 Oct; 166(4):646-51. PubMed ID: 17007555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining.
    Wang HC; Chou WC; Shieh SY; Shen CY
    Cancer Res; 2006 Feb; 66(3):1391-400. PubMed ID: 16452194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner.
    Gibson SL; Bindra RS; Glazer PM
    Cancer Res; 2005 Dec; 65(23):10734-41. PubMed ID: 16322218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
    Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
    Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
    Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK
    Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining.
    Zhuang J; Zhang J; Willers H; Wang H; Chung JH; van Gent DC; Hallahan DE; Powell SN; Xia F
    Cancer Res; 2006 Feb; 66(3):1401-8. PubMed ID: 16452195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible degradation of checkpoint kinase 2 links to cisplatin-induced resistance in ovarian cancer cells.
    Zhang P; Gao W; Li H; Reed E; Chen F
    Biochem Biophys Res Commun; 2005 Mar; 328(2):567-72. PubMed ID: 15694385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of BRCA1 phosphorylation by interaction with protein phosphatase 1alpha.
    Liu Y; Virshup DM; White RL; Hsu LC
    Cancer Res; 2002 Nov; 62(22):6357-61. PubMed ID: 12438214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1.
    Park I; Avraham HK
    Exp Cell Res; 2006 Jul; 312(11):1996-2008. PubMed ID: 16630610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATR dependent activation of Chk2.
    Wang XQ; Redpath JL; Fan ST; Stanbridge EJ
    J Cell Physiol; 2006 Sep; 208(3):613-9. PubMed ID: 16741947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response.
    Lee JS; Collins KM; Brown AL; Lee CH; Chung JH
    Nature; 2000 Mar; 404(6774):201-4. PubMed ID: 10724175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of the tumour-suppressor genes CHK2 and BRCA1 results in chromosomal instability.
    Stolz A; Ertych N; Bastians H
    Biochem Soc Trans; 2010 Dec; 38(6):1704-8. PubMed ID: 21118151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein phosphatase 2A interacts with Chk2 and regulates phosphorylation at Thr-68 after cisplatin treatment of human ovarian cancer cells.
    Liang X; Reed E; Yu JJ
    Int J Mol Med; 2006 May; 17(5):703-8. PubMed ID: 16596250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways.
    Lou Z; Minter-Dykhouse K; Wu X; Chen J
    Nature; 2003 Feb; 421(6926):957-61. PubMed ID: 12607004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide and adriamycin but not genistein can activate the checkpoint kinase Chk2 independently of ATM/ATR.
    Théard D; Coisy M; Ducommun B; Concannon P; Darbon JM
    Biochem Biophys Res Commun; 2001 Dec; 289(5):1199-204. PubMed ID: 11741320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1.
    Melchionna R; Chen XB; Blasina A; McGowan CH
    Nat Cell Biol; 2000 Oct; 2(10):762-5. PubMed ID: 11025670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaboration of Brca1 and Chk2 in tumorigenesis.
    McPherson JP; Lemmers B; Hirao A; Hakem A; Abraham J; Migon E; Matysiak-Zablocki E; Tamblyn L; Sanchez-Sweatman O; Khokha R; Squire J; Hande MP; Mak TW; Hakem R
    Genes Dev; 2004 May; 18(10):1144-53. PubMed ID: 15131084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of DNA-dependent protein kinase leads to spindle disruption and mitotic catastrophe with attenuated checkpoint protein 2 Phosphorylation in response to DNA damage.
    Shang ZF; Huang B; Xu QZ; Zhang SM; Fan R; Liu XD; Wang Y; Zhou PK
    Cancer Res; 2010 May; 70(9):3657-66. PubMed ID: 20406977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1.
    Kim SS; Cao L; Li C; Xu X; Huber LJ; Chodosh LA; Deng CX
    Mol Cell Biol; 2004 Nov; 24(21):9498-507. PubMed ID: 15485917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.